10 completed. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 10 |
Follow Lispro: new trials by email Literature Review of Lispro trials Research Report on Lispro
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes Dapagliflozin, Glargine - Type2diabetes, Coronary Artery Disease | Phase 4 | Completed | Medanta, The Medicity, India | 250 | 2022-07-29 | 2023-10-19 |
| SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H) Sitagliptin 100mg, Glargine, Lispro - Type 2 Diabetes | Phase 4 | Completed | Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social | 76 | 2022-07-06 | 2023-09-26 |
| Remission Through Early Monitored Insulin Therapy - Duration Month Glargine, Lispro, Dexcom G6 - Type 2 Diabetes Mellitus | Phase 4 | Completed | Sandra Sobel | 10 | 2019-03-26 | 2021-10-12 |
| Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy Exenatide, Lispro - Diabetic Nephropathies | Phase 4 | Completed | Nanfang Hospital, Southern Medical University | 92 | 2016-04-08 | 2020-03-09 |
| CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Commercial Hylenex® recombinant (hyaluronidase human injection), Precommercial Hylenex recombinant (hyaluronidase human injection), Insulin lispro - Type 1 Diabetes Mellitus | Phase 4 | Completed | Halozyme Therapeutics | 456 | 2013-03-01 | 2018-11-07 |
| Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase Sham Injection, Recombinant human hyaluronidase PH20, Insulin aspart - Type 1 Diabetes Mellitus | Phase 4 | Completed | Halozyme Therapeutics | 25 | 2011-12-01 | 2019-02-26 |
| Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes Sitagliptin, glargine, lispro - Type 2 Diabetes Mellitus, Hospitalization | Phase 4 | Completed | Emory University | 90 | 2011-08-01 | 2018-12-07 |
| A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes Lispro - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Eli Lilly and Company | 72 | 2010-10-01 | 2014-04-03 |
| Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia NPH insulin plus Complete Insulin Orders, Complete Insulin Orders - Hyperglycemia | Phase 4 | Completed | HealthPartners Institute | 72 | 2010-08-01 | 2018-06-13 |
| The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) Insulin glargine, Lispro Low Mix, Lispro Mid Mix - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Eli Lilly and Company | 2091 | 2005-12-01 | 2011-02-21 |
Diabetes Mellitus, Type 2 (5) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Hyperglycemia (2) · Coronary Artery Disease (1) · Diabetic Nephropathies (1)
Eli Lilly and Company (2) · Halozyme Therapeutics (2) · Emory University (1) · HealthPartners Institute (1) · Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social (1) · Medanta, The Medicity, India (1) · Nanfang Hospital, Southern Medical University (1) · Sandra Sobel (1)
United States (6) · India (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · Finland (1) · Greece (1) · Hungary (1) · Mexico (1) · Netherlands (1) · Puerto Rico (1) · Romania (1) · Spain (1)
Abraham Edgar Gracia-Ramos, MD, MSc (1) · David A Rometo, MD (1) · Douglas Muchmore, MD (1) · Guillermo Umpierrez, MD (1) · Linda Morrow, MD (1) · Linda Siminerio, RN PhD (1) · Richard M Bergenstal, MD (1) · Sandra I Sobel, MD (1) · Shari Reynolds (1)
PMID 19276235, PMID 19336625, PMID 19885269, PMID 19929994, PMID 20685497, PMID 21270182, PMID 23101951, PMID 23757434, PMID 23877988, PMID 24092662, PMID 25881510, PMID 26492541, PMID 26684274, PMID 26731258, PMID 31119456, PMID 31912605, PMID 37380728, PMID 38581842, PMID 39963952